clinical trial Archive — Page 10 of 16

The clinical trial group includes, from left, Gordon Bernard, MD, Katherine Cahill, MD, Kevin Niswender, MD, PhD, Pingsheng Wu, PhD, and R. Stokes Peebles, MD.
November 10, 2022

Clinical trial at VUMC tests novel treatment for asthma

VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.

Red heart-shaped object on blue electrocardiogram grid paper with black heartbeat waveforms.
November 10, 2022

Study defines role of steroids in congenital heart disease surgery

Steroids are commonly given to infants during open-heart surgery to reduce inflammation, but whether the drugs significantly improve patient outcomes has not been settled — until now.

Three-dimensional illustration of a coronavirus particle with a textured gray spherical surface, red spike proteins, and smaller yellow surface structures; blurred particles appear in the background.
November 4, 2022

Study finds Moderna’s COVID-19 vaccine safe and effective for young children

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
October 18, 2022

VUMC implants first patient in NAUTILUS study for treatment of idiopathic generalized epilepsy

A Vanderbilt patient with idiopathic generalized epilepsy is now the first to receive neuromodular stimulation of the brain to see if it can help with seizures.

A Vanderbilt study shows that reducing consumption of simple sugars helped improve gastroesophageal reflux disease.
October 6, 2022

Study finds that reducing intake of simple sugars improves GERD

A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.

Gloved hands hold a blood sample tube labeled “Monkeypox,” with the positive box checked.
September 7, 2022

VUMC study will evaluate alternative strategies for administering mpox vaccine

Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms.